First Midwest Bank Trust Division’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-23,171
| Closed | -$657K | – | 391 |
|
|
2020
Q4 | $657K | Sell |
23,171
-7,174
| -24% | -$203K | 0.1% | 206 |
|
|
2020
Q3 | $763K | Buy |
+30,345
| New | +$763K | 0.12% | 183 |
|
|
2019
Q4 | – | Sell |
-67,141
| Closed | -$873K | – | 380 |
|
|
2019
Q3 | $873K | Sell |
67,141
-37,322
| -36% | -$485K | 0.13% | 175 |
|
|
2019
Q2 | $1.36M | Buy |
+104,463
| New | +$1.36M | 0.19% | 135 |
|
|
2019
Q1 | – | Sell |
-20,399
| Closed | -$411K | – | 391 |
|
|
2018
Q4 | $411K | Sell |
20,399
-19,561
| -49% | -$394K | 0.06% | 269 |
|
|
2018
Q3 | $993K | Buy |
39,960
+14,986
| +60% | +$372K | 0.13% | 171 |
|
|
2018
Q2 | $686K | Buy |
+24,974
| New | +$686K | 0.1% | 227 |
|